我国双一流高校药学论文的文献计量分析

目的 应用文献计量学方法，统计分析我国双一流高校发表药学论文情况，以期了解药学学科发展现况，为高校建设和学科发展提供参考。方法 通过中国知网、万方、维普数据库，以及Scopus数据库检索文献，剔除重复的文献和非研究性文献。共纳入文献12 028篇。采用Excel 2016软件进行统计分析。结果 2014至2019年，各高校总发文量逐年增长，最高增幅为14%。2014至2020年，各高校在国际期刊上发文11 178篇，国内期刊发文850篇，有近93%的药学论文流向国外期刊。在国际期刊上发文数量最多的是北京协和医学院，发表SCI论文最多的是中山大学。在国内期刊上发文数量最多的是北京大学，在国内刊Q1区发文数量和占比均较高的是复旦大学。各高校开展国际合著均较少，多限于本省/直辖市内的合作。结论 双一流高校应重点加强国际间合作和跨省市合作，深入推进产学研协作，加快成果转化。

Bibliometric analysis of pharmaceutical papers from Double First-rate universities in China

Objective To understand the development status in the subject of pharmacy and provide recommendations for the construction of universities and the development of pharmacy by the bibliometric analysis of pharmaceutical papers from Double First-rate universities in China.Methods China National Knowledge Network (CNKI), Wanfang and VIP databases were searched for Chinese literature, and Scopus database was searched for English literature. Duplicates and non-research literatures were deleted. 12 028 literatures were included. Excel 2016 software was used for statistical analysis.Results From 2014 to 2019, the total number of papers published by Double First-rate universities increased year by year, with the highest increase rate of 14%. From 2014 to 2020, 11 178 papers were published in international journals, while only 850 were published in domestic journals. Nearly 93% of pharmaceutical papers flowed to foreign journals. Peking Union Medical College published the most papers in international journals. Sun Yat-sen University published the most SCI papers. Peking University published the most papers in domestic journals, while Fudan University published the highest number of papers in Q1 area. Only a few papers published with international coauthors from colleges or universities. The cooperation works were limited in the same province or municipality directly under the central government.Conclusion Double First-rate universities should focus on strengthening international cooperation and inter-provincial cooperation, improving industry-university collaboration, and accelerating the transformation from scholar research to productions.